Mobile

A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-003439-41

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To evaluate the efficacy of VX 509 across a range of doses • To evaluate the early effect of VX 509 administration on joint structures as assessed by magnetic resonance imaging (MRI)

Critère d'inclusion

  • Rheumatoid Arthritis

Liens